Brief: Harvard Apparatus Regenerative Technology Announces Strategic Collaboration With Children’S Hospital Capital Institute Of Pediatrics In Beijing, China To Advance Treatment For Esophageal Atresia
28/10/2024 13:09
Oct 28 (Reuters) - Harvard Apparatus Regenerative
Technology Inc HRGN.PK :
* HARVARD APPARATUS REGENERATIVE TECHNOLOGY ANNOUNCES
STRATEGIC
COLLABORATION WITH CHILDREN’S HOSPITAL CAPITAL INSTITUTE OF
PEDIATRICS IN BEIJING, CHINA TO ADVANCE TREATMENT FOR ESOPHAGEAL
ATRESIA
Source text: ID:nGNX11CByl
Further company coverage: HRGN.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Harvard Apparatus Regenerative Technology
See all newsBrief: Harvard Apparatus Regenerative Technology Announces Strategic Collaboration With Children’S Hospital Capital Institute Of Pediatrics In Beijing, China To Advance Treatment For Esophageal Atresia
Brief: Biostage Activated Mayo Clinic As The First Site For Clinical Trial In Severe Esophageal Disease
Brief: Biostage Amends CEO Employment Agreement
Brief: Biostage Inc Files For Firm Commitment Public Offering Of 1.03 Million Units - SEC Filing
Brief: Biostage Announces Appointment Of New Chief Financial Officer